OpenEvidence, a tool that doctors and nurses have likened to ChatGPT for medicine, plans to announce a $200 million raise at a $6 billion valuation, The New York Times reports.
The fresh funds come three months after the startup raised a $210 million round at a $3.5 billion valuation, a testament to the intense investor interest in industry-specific AI applications.
Trained on medical journals from JAMA and the New England Journal of Medicine, the OpenEvidence platform helps users quickly get answers to existing medical knowledge to help treat patients. Verified medical professionals can access OpenEvidence’s tool, which is supported by advertising, for free.
OpenEvidence has grown quickly since its founding in 2022. Its number of clinical consultations per month has nearly doubled to 15 million since July, per the Times.
The round was led by Google Ventures, with participation from Sequoia Capital, Kleiner Perkins, Blackstone, Thrive Capital, Coatue Management, Bond, and Craft.
TechCrunch has reached out to OpenEvidence for comment.
2-FOR-1 DISCOUNT: Bring a +1 and save 60%
Google Cloud, Netflix, Microsoft, Box, Phia, a16z, ElevenLabs, Wayve, Hugging Face, Elad Gil, Vinod Khosla — some of the 250+ heavy hitters leading 200+ sessions designed to deliver the insights that fuel startup growth and sharpen your edge. And don’t miss 300+ showcasing startups in all sectors.
Bring a +1 and save 60% on their pass, or get your pass by Oct 27 to save up to $444.
2-FOR-1 DISCOUNT: Bring a +1 and save 60%
Google Cloud, Netflix, Microsoft, Box, Phia, a16z, ElevenLabs, Wayve, Hugging Face, Elad Gil, Vinod Khosla — some of the 250+ heavy hitters leading 200+ sessions designed to deliver the insights that fuel startup growth and sharpen your edge. And don’t miss 300+ showcasing startups in all sectors. Bring a +1 and save 60% on their pass, or get your pass by Oct 27 to save up to $444.
|
October 27-29, 2025
Original Source: https://techcrunch.com/2025/10/20/openevidence-the-chatgpt-for-doctors-raises-200m-at-6b-valuation/
Disclaimer: This article is a reblogged/syndicated piece from a third-party news source. Content is provided for informational purposes only. For the most up-to-date and complete information, please visit the original source. Digital Ground Media does not claim ownership of third-party content and is not responsible for its accuracy or completeness.
